2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Hypopigmentation in 2 studies
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source
Hypopigmentation: A condition caused by a deficiency or a loss of melanin pigmentation in the epidermis, also known as hypomelanosis. Hypopigmentation can be localized or generalized, and may result from genetic defects, trauma, inflammation, or infections.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Punicalagin is a phenolic compound with antioxidant properties." | 1.46 | Dual hypopigmentary effects of punicalagin via the ERK and Akt pathways. ( Cho, JH; Jeong, HS; Kim, DS; Kim, MK; Kwon, NS; Lee, H; Shin, JS; Yun, HY, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shin, JS | 1 |
| Cho, JH | 1 |
| Lee, H | 1 |
| Jeong, HS | 2 |
| Kim, MK | 1 |
| Yun, HY | 2 |
| Kwon, NS | 2 |
| Kim, DS | 2 |
| Lee, SH | 1 |
| Baek, KJ | 1 |
| Park, KC | 1 |
2 other studies available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Hypopigmentation
| Article | Year |
|---|---|
Dual hypopigmentary effects of punicalagin via the ERK and Akt pathways.
Topics: Animals; Antioxidants; Cell Line, Transformed; Chromones; Enzyme Inhibitors; Flavonoids; Hydrolyzabl | 2017 |
Involvement of mTOR signaling in sphingosylphosphorylcholine-induced hypopigmentation effects.
Topics: Analysis of Variance; Animals; Blotting, Western; Cell Line; Chromones; Dose-Response Relationship, | 2011 |